Japan has deep neuroscience infrastructure, long-running public programs, and an emerging neurotechnology startup layer. Its position is distinct from larger U.S. and Chinese markets, with strength in research, robotics, manufacturing, and governance, but a less defined path to clinical translation and global scale.